242 related articles for article (PubMed ID: 1129845)
41. Can neo-adjuvant chemotherapy prevent residual tumors?
Bourut C; Chenu E; Mathé G
Suppl J Med Oncol Tumor Pharmacother; 1988; 1():59-63. PubMed ID: 2977811
[No Abstract] [Full Text] [Related]
42. The combined effect of radiotherapy and neuraminidase-treated tumor cells on 3-methylcholanthrene-induced fibrosarcoma.
So SK; Song CW; Rios A; Simmons RL
J Surg Oncol; 1977; 9(6):527-40. PubMed ID: 592852
[TBL] [Abstract][Full Text] [Related]
43. Some observations on the action of actinomycin D, mitomycin C and jawaharene on transplanted mouse fibrosarcoma.
Roy A; Chatterjee PC
Indian J Cancer; 1974 Dec; 11(4):394-8. PubMed ID: 4468244
[No Abstract] [Full Text] [Related]
44. Failure of immunotherapy with neuraminidase-treated tumor cell vaccine in mice bearing established 3-methylcholanthrene-induced sarcomas.
Spence RJ; Simon RM; Baker AR
J Natl Cancer Inst; 1978 Feb; 60(2):451-9. PubMed ID: 621758
[TBL] [Abstract][Full Text] [Related]
45. Lectin potentiation of BCG-contact-mediated antitumor action.
Poduval TB; Seshadri M; Sundaram K
J Natl Cancer Inst; 1980 Nov; 65(5):909-12. PubMed ID: 6933260
[TBL] [Abstract][Full Text] [Related]
46. In vivo inhibition of tumor growth by cyclic adenosine 3',5'-monophosphate derivatives.
Cho-Chung YS
Cancer Res; 1974 Dec; 34(12):3492-6. PubMed ID: 4371966
[No Abstract] [Full Text] [Related]
47. [Experiments on the treatment of Yoshida tumor with neuroaminidase of Vibrio cholerae].
Sánchez Cousteau JA; Justo Alpañes E; Ledro Molina D; Ferreiro Madueño M; Gomez Parra M; Ramírez Martínez R; Valle Bernal MJ; Astolfi Pérez de Guzmán J; Garrido Peralta M
Rev Clin Esp; 1979 Sep; 154(5):183-6. PubMed ID: 523718
[No Abstract] [Full Text] [Related]
48. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
[TBL] [Abstract][Full Text] [Related]
49. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
Milas L; Hunter N; Mason K; Withers HR
Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
[No Abstract] [Full Text] [Related]
50. Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice.
Milas L; Hunter N; Withers HR
Cancer Res; 1974 Mar; 34(3):613-20. PubMed ID: 4590922
[No Abstract] [Full Text] [Related]
51. Immunotherapeutic effect of tumor necrosis in situ.
Neel HB; Ritts RE
Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1977; 84(2):285-90. PubMed ID: 898501
[No Abstract] [Full Text] [Related]
52. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
Sirotnak FM; Otter GM; Schmid FA
Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
[TBL] [Abstract][Full Text] [Related]
53. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
Basombrío MA; Prehn RT
Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
[No Abstract] [Full Text] [Related]
54. Host resistance against tumor and its synergic effect with cancer chemotherapy.
Sato R
Gan; 1967 Jun; 58(3):211-20. PubMed ID: 6081225
[No Abstract] [Full Text] [Related]
55. Transplantability and antigenicity of two sublines of the TA3 tumor.
Sanford BH; Codington JF; Jeanloz RW; Palmer PD
J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
[No Abstract] [Full Text] [Related]
56. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
Jurin M; Suit HD
Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
[No Abstract] [Full Text] [Related]
57. Immunological studies in murine osteosarcoma. Immunogenicity, growth kinetics, and immunotherapy.
Miller CW; DeBlasi RF; Fisher SJ
J Bone Joint Surg Am; 1976 Apr; 58(3):312-7. PubMed ID: 1063129
[TBL] [Abstract][Full Text] [Related]
58. Experimental cancer immunotherapy: modification of tumor cells to increase immunogenicity.
Rios A; Simmons RL
Ann N Y Acad Sci; 1976; 276():45-60. PubMed ID: 68699
[TBL] [Abstract][Full Text] [Related]
59. Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division.
Reznikoff CA; Bertram JS; Brankow DW; Heidelberger C
Cancer Res; 1973 Dec; 33(12):3239-49. PubMed ID: 4796800
[No Abstract] [Full Text] [Related]
60. Enzymically-mediated changes in murine mammary adenocarcinoma cell membrane induces changes in lymphoid tissue immune ribonucleic acids.
Hakim AA
Arch Geschwulstforsch; 1980; 50(7):613-27. PubMed ID: 6165333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
